Pediatrix Medical Group, Inc. (NYSE:MD) Receives Average Recommendation of “Hold” from Brokerages

Pediatrix Medical Group, Inc. (NYSE:MD) has been assigned an average rating of “Hold” from the four brokerages that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $10.30.

MD has been the subject of a number of research reports. TheStreet cut shares of Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd. Jefferies Financial Group lowered their price target on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. Mizuho lowered their price target on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st. Finally, Truist Financial lowered their price target on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a report on Wednesday, February 21st.

Hedge Funds Weigh In On Pediatrix Medical Group

Several institutional investors have recently made changes to their positions in the business. Pacer Advisors Inc. grew its holdings in Pediatrix Medical Group by 126.9% during the 4th quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock valued at $30,092,000 after buying an additional 1,809,828 shares in the last quarter. Boston Partners purchased a new stake in Pediatrix Medical Group during the 4th quarter valued at approximately $12,452,000. Invenomic Capital Management LP grew its holdings in Pediatrix Medical Group by 93.3% during the 4th quarter. Invenomic Capital Management LP now owns 1,377,951 shares of the company’s stock valued at $12,815,000 after buying an additional 664,955 shares in the last quarter. Clark Estates Inc. NY purchased a new stake in Pediatrix Medical Group during the 4th quarter valued at approximately $3,302,000. Finally, Envestnet Asset Management Inc. grew its holdings in Pediatrix Medical Group by 250.6% during the 3rd quarter. Envestnet Asset Management Inc. now owns 267,434 shares of the company’s stock valued at $3,399,000 after buying an additional 191,154 shares in the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Down 1.8 %

MD opened at $9.24 on Thursday. The firm has a market capitalization of $776.02 million, a P/E ratio of -12.65, a PEG ratio of 2.44 and a beta of 1.58. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24. Pediatrix Medical Group has a fifty-two week low of $7.70 and a fifty-two week high of $15.06. The company’s 50-day moving average is $9.21 and its 200 day moving average is $9.64.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, February 20th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.02. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The company had revenue of $496.44 million for the quarter, compared to analyst estimates of $524.30 million. During the same quarter in the previous year, the firm posted $0.46 earnings per share. The company’s quarterly revenue was down 3.4% compared to the same quarter last year. Research analysts expect that Pediatrix Medical Group will post 1.12 earnings per share for the current fiscal year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.